26-P-00188-EBO-Determination-Letter-SLBE.pdf

This is an Equal Business Opportunity (EBO) Determination Letter issued by the City of Tampa's Purchasing Department for the Advanced Life Support Medications procurement (Project No. 26-P-00188). The solicitation seeks sealed bids for four specific medication line items required by Tampa Fire Rescue: 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials. Electronic bids must be submitted through the OpenGov eProcurement Portal by 3:00 pm on Wednesday, April 8, 2026, with award to be made to the lowest responsive, responsible bidder within 120 days of bid opening. All medications must maintain an expiration date of nine months or more from the date of acceptance, with delivery required within ten calendar days of order receipt. The contract term is one year from the effective award date of March 10, 2026, with options to renew by mutual written agreement for two additional one-year periods, plus the City reserves the right to unilaterally extend the contract for up to three additional 30-day periods.

The estimated contract value is $40,000.00. This procurement has been designated as a Sheltered Market for Small Local Business Enterprises (SLBEs), with a 5 percent bid discount available to SLBE bidders not to exceed $10,000. No subcontracting goals for certified SLBEs were established for this project, as the scope did not meet narrowly tailored requirement parameters. All bid prices must be firm and include shipping costs, freight on board to Tampa, Florida, and applicable taxes. Vendors must warrant that all materials are free from defects for a minimum of 365 days and arrange for pickup and replacement of expired materials. Bidders utilizing SLBEs as subcontractors must submit a Schedule of Subcontractors (DMI-20 Form) and Letter of Intent (DMI-40 Form) within ten workdays after notice of intent to award. Additionally, vendors must provide comprehensive accessibility documentation conforming to WCAG 2.2 Level AA standards and Section 508 requirements, as well as Safety Data Sheets compliant with OSHA Hazard Communication Standards for all medications supplied.